Consultorio de Investigación Clínica EMO SRL

Ciudad Autonoma de Buenos Aires, Buenos Aires C1405BUB

0 studies enrolling now · 2 studies all time

What they study most

Obesity, Overweight, Type 2 Diabetes

Studies at this site

• A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity — Running, not enrolling
• A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight — Completed